Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel L Simmons

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Thrombosis Research|November 1, 2003
Variants of cyclooxygenase-1 and their roles in medicineDaniel L Simmons
Genome Biology|September 4, 2004
The cyclooxygenasesN V Chandrasekharan, Daniel L Simmons
Handbook of Clinical Neurology|November 22, 2018
Antipyretic therapy: clinical pharmacologyJonathan J Lee, Daniel L Simmons
Biochemical and Biophysical Research Communications|August 30, 2005
Cyclooxygenase variants: the role of alternative splicingK Lamar Turepu Roos, Daniel L Simmons
Pharmacological Reviews|August 20, 2004
Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibitionDaniel L Simmons, Regina M Botting, Timothy Hla
Journal of Ethnopharmacology|February 23, 2007
Trifunctional inhibition of COX-2 by extracts of Lonicera japonica: direct inhibition, transcriptional and post-transcriptional down regulationYibing Xu, Bryant G Oliverson, Daniel L Simmons
Pharmacological Reviews|October 7, 2009
Answering the burning question of how transient receptor potential vanilloid-1 channel antagonists cause unwanted hyperthermiaSamir S Ayoub, John C Hunter, Daniel L Simmons
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
Expression of cyclooxygenase isoforms in the baculovirus expression systemJohn C Hunter, Natalie M Myres, Daniel L Simmons
Journal of Genetics and Genomics = Yi Chuan Xue Bao|March 16, 2010
The N-terminus of COX-1 and its effect on cyclooxygenase-1 catalytic activityYibing Xu, Sean Phipps, Michael J Turner, et al.
Cell|October 19, 2020
Raymond L. Erikson (1936-2020)Benjamin G Neel, Laurel Sweet, Daniel L Simmons, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Thrombosis Research|November 1, 2003
Variants of cyclooxygenase-1 and their roles in medicineDaniel L Simmons
Genome Biology|September 4, 2004
The cyclooxygenasesN V Chandrasekharan, Daniel L Simmons
Handbook of Clinical Neurology|November 22, 2018
Antipyretic therapy: clinical pharmacologyJonathan J Lee, Daniel L Simmons
Biochemical and Biophysical Research Communications|August 30, 2005
Cyclooxygenase variants: the role of alternative splicingK Lamar Turepu Roos, Daniel L Simmons
Pharmacological Reviews|August 20, 2004
Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibitionDaniel L Simmons, Regina M Botting, Timothy Hla
Journal of Ethnopharmacology|February 23, 2007
Trifunctional inhibition of COX-2 by extracts of Lonicera japonica: direct inhibition, transcriptional and post-transcriptional down regulationYibing Xu, Bryant G Oliverson, Daniel L Simmons
Pharmacological Reviews|October 7, 2009
Answering the burning question of how transient receptor potential vanilloid-1 channel antagonists cause unwanted hyperthermiaSamir S Ayoub, John C Hunter, Daniel L Simmons
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
Expression of cyclooxygenase isoforms in the baculovirus expression systemJohn C Hunter, Natalie M Myres, Daniel L Simmons
Journal of Genetics and Genomics = Yi Chuan Xue Bao|March 16, 2010
The N-terminus of COX-1 and its effect on cyclooxygenase-1 catalytic activityYibing Xu, Sean Phipps, Michael J Turner, et al.
Cell|October 19, 2020
Raymond L. Erikson (1936-2020)Benjamin G Neel, Laurel Sweet, Daniel L Simmons, et al.
Pageof 2